Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine

Clinical trial NCT01449812 · COMPLETED

Trial details

NCT number: NCT01449812
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acellular Pertussis Tetanus Diphtheria Haemophilus Influenzae Type b

Start date: 2011-10-01
Primary completion: 2012-01-16
Enrollment: 831

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.